Patents by Inventor Chrystelle Lamagna

Chrystelle Lamagna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BICYCLIC INHIBITORS OF IRAK
    Publication number: 20230391748
    Abstract: Disclosed embodiments concern novel interleukin receptor associated kinases (IRAK) inhibitor compounds and compositions comprising such compounds. The compounds may have a structure according to Formula I Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent an IRAK-associated disease or condition.
    Type: Application
    Filed: May 31, 2023
    Publication date: December 7, 2023
    Inventors: Yan Chen, Esteban Masuda, Chrystelle Lamagna
  • TRICYCLIC IRAK INHIBITORS
    Publication number: 20230312568
    Abstract: Disclosed embodiments concern compounds according to Formula I In some embodiments, the compounds are useful as kinase inhibitors, such as interleukin receptor associated kinases (IRAK) inhibitors. Also disclosed are compositions comprising such inhibitors, and methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent a kinase-associated disease or condition, particularly an IRAK-associated disease or condition.
    Type: Application
    Filed: March 30, 2023
    Publication date: October 5, 2023
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Zhushou Luo, Simon Shaw, Ihab Darwish, Estaban Masuda, Chrystelle Lamagna